Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anal cancer: current standards in care and recent changes in practice.

Literature DB >> 25582527

Anal cancer: current standards in care and recent changes in practice.

Ravi Shridhar¹, David Shibata, Emily Chan, Charles R Thomas.

Abstract

Answer questions and earn CME/CNE The management of squamous cell carcinomas of the anal canal has evolved from surgery as first-line treatment to curative chemoradiation, with surgery reserved for salvage. Significant progress has been made in understanding how to most effectively deliver chemotherapy and reduce toxicity through advancements in radiation delivery. The purpose of this article is to review the multimodality approach to the diagnosis and management of anal cancer based on a review of the published data and in light of available guidelines.

Entities: Disease

Keywords: abdominoperineal resection; anal cancer; brachytherapy; chemoradiation; chemotherapy; intensity modulated radiation therapy; quality of life; salvage therapy; sentinel lymph node biopsy; squamous cell carcinoma

Mesh：

Year: 2015 PMID： 25582527 DOI： 10.3322/caac.21259

Source DB: PubMed Journal: CA Cancer J Clin ISSN： 0007-9235 Impact factor: 508.702

Keyword Cloud
Cited

27 in total

1. Delayed Diagnosis of Anal Cancer.

Authors: Katherine Bingmer; Asya Ofshteyn; Sharon L Stein; Emily Steinhagen
Journal: J Gastrointest Surg Date: 2019-08-16 Impact factor: 3.452

Review 2. Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.

Authors: Guillaume Klausner; Eivind Blais; Raphaël Jumeau; Julian Biau; Mailys de Meric de Bellefon; Mahmut Ozsahin; Thomas Zilli; Raymond Miralbell; Juliette Thariat; Idriss Troussier
Journal: Med Oncol Date: 2018-08-20 Impact factor: 3.064

3. Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

Authors: L Cattelan; F M Ghazawi; M Le; E Savin; A Zubarev; F Lagacé; D Sasseville; K Waschke; I V Litvinov
Journal: Curr Oncol Date: 2020-06-01 Impact factor: 3.677

4. Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

Authors: Madhur K Garg; Fengmin Zhao; Joseph A Sparano; Joel Palefsky; Richard Whittington; Edith P Mitchell; Mary F Mulcahy; Karin I Armstrong; Nassim H Nabbout; Shalom Kalnicki; Bassel F El-Rayes; Adedayo A Onitilo; Daniel J Moriarty; Thomas J Fitzgerald; Al B Benson
Journal: J Clin Oncol Date: 2017-01-09 Impact factor: 44.544

5. A Case Series of Anal Carcinoma Misdiagnosed as Idiopathic Chronic Anal Fissure.

Authors: Sandra Barbeiro; Catarina Atalaia-Martins; Pedro Marcos; Cláudia Gonçalves; Isabel Cotrim; Helena Vasconcelos
Journal: GE Port J Gastroenterol Date: 2016-11-30

6. Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.

Authors: Veronica Dell'Acqua; Alessia Surgo; Simona Arculeo; Maria Alessia Zerella; Vincenzo Bagnardi; Samuele Frassoni; Maria Giulia Zampino; Paola Simona Ravenda; Maria Saveria Rotundo; Fatjona Kraja; Jarek Kobiela; Piotr Spychalski; Cristiana Fodor; Marianna Alessandra Gerardi; Federica Cattani; Alessia Bazani; Wanda Petz; Robert Glynne-Jones; Roberto Orecchia; Maria Cristina Leonardi; Barbara Alicja Jereczek-Fossa
Journal: Int J Colorectal Dis Date: 2020-02-08 Impact factor: 2.571

Anal cancer: current standards in care and recent changes in practice.

1. Delayed Diagnosis of Anal Cancer.

Review 2. Management of locally advanced anal canal carcinoma with intensity-modulated radiotherapy and concurrent chemotherapy.

3. Investigating epidemiologic trends and the geographic distribution of patients with anal squamous cell carcinoma throughout Canada.

4. Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).

5. A Case Series of Anal Carcinoma Misdiagnosed as Idiopathic Chronic Anal Fissure.

6. Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.

7. The Role of Multiagent Chemoradiation in the Management and Prognosis of Anal Squamous Cell Carcinoma.

8. Toxicity and survival of anal cancer patients treated with intensity-modulated radiation therapy.

9. Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research.

10. Evaluation of anal cytology and dysplasia in women with a history of lower genital tract dysplasia and malignancy.